不同类皮质类固醇对社区获得的严重肺炎的影响:系统性审查和元分析
Xin Ya See1, Tsu Hsien Wang2, Yu-Cheng Chang3
1Department of Medicine, Unity Hospital, Rochester Regional Health, Rochester, New York, USA.
BMJ open respiratory research
|January 23, 2024
概括
皮显著降低了严重的社区获得性肺炎 (CAP) 的死亡率. 这项研究发现,与其他皮质类固醇不同,水皮质可以改善治疗结果并减少并发症,而不会增加住院CAP患者的不良事件.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于皮质类固醇在严重社区获得性肺炎 (CAP) 中的疗效存在相互矛盾的结果.
- 在住院的严重CAP患者中研究各种皮质类固醇的差异效应至关重要.
结论:
- 皮与降低死亡率和改善严重CAP的结果有关.
- 其他皮质类固醇 (甲基甲松,甲基前松,前松) 并没有显示出类似的益处.
- 皮似乎是严重CAP的安全有效的治疗选择.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
251
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
251
01:28Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
01:30Pneumonia III: Complications and Assessment
225
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
225
01:29Pneumonia II: Pathophysiology
274
The pathophysiology of pneumonia involves the following steps:
274